Skip to main content
OpenTrials
Completed

NCT Number: NCT00553293

Nordic Luveris Study

To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases In Vitro Fertilization Urogenital Diseases

Age range

21 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Anders Nyboe Andersen

Copenhagen, 2100, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age below 40
  • Infertility treatable by IVF or ICSI
  • Regular cycles

Exclusion criteria

  • NA

Treatment and study plan

recombinant luteinizing hormone (Luveris)

Drug

75 iu/day form cycle day 6

Other names: Luveris

recombinant follicle stimulating hormone (Gonal-f)

Drug

rFSH 150 iu/day

Other names: Gonal-f

Primary outcomes

  1. Ongoing pregnancy rate per started stimulation cycle

    Time frame: ultrasound showing ongoing pregnancy

Secondary outcomes

  1. Ongoing pregnancy in subgroups of patients with lo0w serum LH levels

    Time frame: ultrasound for ongoing pregnancy in subgroups

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Collaborators

  • Helse Fonna
  • Herlev Hospital
  • Holbaek Sygehus
  • Hvidovre University Hospital
  • Karolinska University Hospital
  • Odense University Hospital
  • Regionshospitalet Viborg, Skive
  • Turku Hospital

Registry information

Official study title

Recombinant LH Supplementation to Recombinant FSH During the Final Days of Controlled Ovarian Stimulation for IVF: a Multicentre, Prospective, Randomized, Controlled Trial

Important dates

Study start
2003
Study completion
2004
First posted
Nov 5, 2007
Registry last updated
Nov 5, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.